Updating results

2711 results

Sort: Relevance | Date

Safer insulin prescribing (KTT20)

KTT20 Safer insulin prescribing Key points Several new insulin products have been launched

Key therapeutic topic Published January 2017 Last updated September 2019

Complicated urinary tract infections: ceftolozane/tazobactam (ESNM74)

Summary of the evidence on ceftolozane/tazobactam for treating complicated urinary tract infections to inform local NHS planning and decision-making

Evidence summary Published June 2016

Chronic obstructive pulmonary disease: beclometasone, formoterol and glycopyrronium (Trimbow) (ES17)

Summary of the evidence on beclometasone, formoterol and glycopyrronium (Trimbow) for chronic obstructive pulmonary disease (COPD) to inform local NHS planning

Evidence summary Published May 2018

RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (MIB109)

Advice on the use of RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (IBD) to aid local decision-making

Medtech innovation briefing Published June 2017

FreeStyle Libre for glucose monitoring (MIB110)

Advice on the use of FreeStyle Libre for monitoring glucose levels in diabetes to aid local decision-making

Medtech innovation briefing Published July 2017 Last updated September 2017

NephroCheck test to help assess the risk of acute kidney injury in critically ill patients (MIB156)

Advice on the use of NephroCheck test (Ortho Clinical Diagnostics) to help assess acute kidney injury risk in critically ill patients to aid local decision

Medtech innovation briefing Published August 2018

Biopatch for venous or arterial catheter sites (MIB117)

Advice on the use of Biopatch hydrophilic foam dressing with chlorhexidine gluconate (CHG) for venous or arterial catheter sites to aid local decision-making

Medtech innovation briefing Published August 2017

Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer (MIB137)

Advice on the use of plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer (NSCLC) to aid local decision-making

Medtech innovation briefing Published January 2018

Fungitell for antifungal treatment stratification (MIB118)

Advice on the use of the Fungitell assay for detecting fungal infections (pathogens, fungus, fungi) in guiding antifungal treatment to aid local decision-making

Medtech innovation briefing Published August 2017

Health app: GDm-Health for people with gestational diabetes (MIB131)

Advice on the GDm-Health app to remotely monitor blood glucose in people with gestational diabetes (diabetes in pregnancy) to aid local decision-making

Medtech innovation briefing Published November 2017

Chemotherapy dose standardisation (KTT22)

KTT22 Chemotherapy dose standardisation Key points Chemotherapy dose standardisation

Key therapeutic topic Published February 2018 Last updated September 2019

EpiFix for chronic wounds (MIB139)

Advice on the use of EpiFix (an allograft comprising dehydrated human amnion/chorion membrane tissue/dHACM) for chronic wounds to aid local decision-making

Medtech innovation briefing Published January 2018

Optowire for measuring fractional flow reserve (MIB199)

Advice on the use of Optowire (sterile, fibreoptic-based, disposable guide wire) for measuring fractional flow reserve (FFR) to aid local decision making

Medtech innovation briefing Published December 2019

Leukomed Sorbact for preventing surgical site infection (MIB197)

Advice on the use of Leukomed Sorbact for preventing surgical site infection (SSI) to aid local decision making

Medtech innovation briefing Published November 2019

End-tidal Control software for use with Aisys closed circuit anaesthesia systems for automated gas control during general anaesthesia (MIB10)

Advice on the use of End-tidal Control software with Aisys closed circuit anaesthesia systems for automated gas control during general anaesthesia..

Medtech innovation briefing Published September 2014

myAIRVO2 for the treatment of chronic obstructive pulmonary disease (MIB161)

Advice on the use of myAIRVO2 (warms and humidifies respiratory gases) for treating chronic obstructive pulmonary disease (COPD) to aid local decision-making

Medtech innovation briefing Published October 2018

OxyMask for delivering oxygen therapy (MIB160)

Advice on the use of OxyMask for delivering oxygen therapy to aid local decision-making

Medtech innovation briefing Published September 2018

UroShield for preventing catheter-associated urinary tract infections (MIB191)

Advice on the use of UroShield for preventing catheter-associated urinary tract infections (CAUTI) to aid local decision making

Medtech innovation briefing Published September 2019

SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea (MIB190)

Advice on the use of SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea to aid local decision making

Medtech innovation briefing Published September 2019

Alpha-Stim AID for anxiety (MIB193)

Advice on the use of Alpha-Stim AID for anxiety to aid local decision making

Medtech innovation briefing Published September 2019

InterDry for intertrigo (MIB192)

Advice on the use of InterDry for intertrigo (inflammatory skin rash) to aid local decision making

Medtech innovation briefing Published September 2019

Antimicrobial prescribing: Ceftazidime/avibactam (ES16)

Summary of the evidence on ceftazidime/avibactam for complicated intra-abdominal and UTI infections and hospital-acquired pneumonia

Evidence summary: antimicrobial prescribing Published November 2017

Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease (MIB132)

Advice on the use of point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease

Medtech innovation briefing Published December 2017

Suicide prevention: optimising medicines and reducing access to medicines as a means of suicide (KTT24)

KTT24 Suicide prevention: optimising medicines and reducing access to medicines as a means of suicide Key points

Key therapeutic topic Published March 2019 Last updated September 2019

Shared decision making (KTT23)

KTT23 Shared decision making Key points In the context of medicines optimisation, shared

Key therapeutic topic Published March 2019 Last updated September 2019

Smart One for measuring lung function (MIB96)

Advice on the use of Smart One for measuring lung function to aid local decision-making

Medtech innovation briefing Published February 2017

eazyplex SuperBug kits for detecting carbapenemase-producing organisms (MIB94)

Advice on the use of eazyplex SuperBug kits for detecting carbapenemase-producing organisms (bacteria) to aid local decision-making

Medtech innovation briefing Published February 2017

Smartinhaler for asthma (MIB90)

Advice on the use of Smartinhaler for monitoring the activation of asthma inhalers to aid local decision-making

Medtech innovation briefing Published January 2017

Alere Afinion CRP for C-reactive protein testing in primary care (MIB81)

Advice on the use of the Alere Afinion CRP for C-reactive protein testing in primary care to aid local decision-making

Medtech innovation briefing Published September 2016

Otovent nasal balloon for otitis media with effusion (MIB59)

Advice on the use of the Otovent nasal balloon for relieving the symptoms of otitis effusion (glue ear) to aid local decision-making

Medtech innovation briefing Published March 2016

The V.A.C. Veraflo Therapy system for infected wounds (MIB189)

Advice on the use of the V.A.C. Veraflo Therapy system for infected wounds to aid local decision making

Medtech innovation briefing Published September 2019

Caris Molecular Intelligence for guiding cancer treatment (MIB120)

Advice on the use of Caris Molecular Intelligence (CMI; solid tumour biomarker analysis service) for guiding cancer treatment to aid local decision-making

Medtech innovation briefing Published September 2017

HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer (MIB128)

Advice on the use of HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer (NSCLC) to aid local decision-making

Medtech innovation briefing Published November 2017

Complicated intra-abdominal infections: ceftolozane/tazobactam (ESNM75)

Summary of the evidence on ceftolozane/tazobactam for treating complicated intra-abdominal infections to inform local NHS planning and decision-making

Evidence summary Published June 2016

Antimicrobial prescribing: meropenem with vaborbactam (ES21)

Summary of the evidence on antimicrobial prescribing of meropenem with vaborbactam (Vaborem) to inform local NHS planning and decision making

Evidence summary Published November 2019

The OraQuick HCV point‑of‑care test for rapid detection of hepatitis C virus antibodies (MIB24)

Advice on the use of the OraQuick HCV point-of-care test for rapid detection of hepatitis C virus antibodies to aid local decision-making

Medtech innovation briefing Published March 2015

S-Cath System for suprapubic catheterisation (MIB68)

Advice on the use of the S-Cath System for suprapubic catheterisation to aid local decision-making

Medtech innovation briefing Published June 2016

Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA‑SC) (ESNM31)

Summary of the evidence on subcutaneous depot medroxyprogesterone acetate (DMPA-SC) for long-acting reversible contraception..

Evidence summary Published January 2014

The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken (Inherited)

The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or

General practice indicator suitable for use in the QOF Published June 2016

The percentage of patients with hypothyroidism, on the register, with thyroid function tests recorded in the preceding 12 months (Inherited)

The percentage of patients with hypothyroidism, on the register, with thyroid function tests recorded in the preceding 12 months (Inherited)

General practice indicator suitable for use in the QOF Published June 2016

The percentage of patients with dementia (diagnosed on or after 1 April 2014) who have a record of attendance at a memory assessment service up to 12 months before entering on to the register

The percentage of patients with dementia (diagnosed on or after 1 April 2014) who have a record of attendance at a memory assessment service up to 12...

General practice indicator suitable for use in the QOF Published June 2016

The percentage of patients with moderate or severe frailty and/or multimorbidity who have received a medication review in the last 12 months which is structured, has considered the use of a recognised tool and taken place as a shared discussion.

The percentage of patients with moderate or severe frailty and/or multimorbidity who have received a medication review in the last 12 months which is...

General practice indicator suitable for use in the QOF Published October 2019

The percentage of patients with dementia with the contact details of a named carer on their record

The percentage of patients with dementia with the contact details of a named carer on their record Subject(s): Dementia

General practice indicator suitable for use in the QOF Published June 2016

The percentage of patients with non-diabetic hyperglycaemia who have had an HbA1c or FPG test in the preceding 12 months

The percentage of patients with non-diabetic hyperglycaemia who have had an HbA1c or FPG test in the preceding 12 months Subject(s):

General practice indicator suitable for use in the QOF Published July 2017

The percentage of patients with diabetes aged 40 years and over, with no history of CVD and without moderate or severe frailty, who are currently treated with a statin (excluding patients with type 2 diabetes and a CVD risk score of

The percentage of patients with diabetes aged 40 years and over, with no history of CVD and without moderate or severe frailty, who are currently...

General practice indicator suitable for use in the QOF Published October 2018

The percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or dementia who have been screened for hazardous drinking using the FAST or AUDIT-C tool in the preceding 2 years.

The percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or...

General practice indicator suitable for use in the QOF Published October 2019

The percentage of patients with diabetes and a history of CVD (excluding haemorrhagic stroke) who are currently treated with a statin

The percentage of patients with diabetes and a history of CVD (excluding haemorrhagic stroke) who are currently treated with a statin

General practice indicator suitable for use in the QOF Published October 2018

The percentage of patients with diabetes, on the register, in whom the last blood pressure reading (measured in the preceding 12 months) is 140/80 mmHg or less

NICE indicators. NM02 Diabetes guidance.

General practice indicator suitable for use in the QOF Published August 2019

The percentage of patients with peripheral arterial disease in whom the last measured total cholesterol (measured in preceding 15 months) is 5.0mmol/l or less

NICE indicators. NM35 peripheral arterial disease guidance.

General practice indicator suitable for use in the QOF Published October 2017